retatrutide drug retatrutide for weight loss: Study shows 30% body weight loss A New Obesity Drug Delivered

Women often notice: Increased abdominal fat, even without changes in diet Slower metabolism and reduced calorie burning Increased insulin resistance Loss of muscle mass Persistent hunger and cravings Difficulty sleeping, which further affects weight regulation These changes are rooted in biology, not willpower

The SURPASS clinical trial program demonstrated superior A1C reductions compared to semaglutide, with many patients achieving normal blood glucose levels

Who Should Not Take Wegovy

Exact dosages are tailored to the patients goals and prescribed by your provider

Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP

Currently under investigation for obesity, type 2 diabetes, and metabolic liver diseases